1. Signaling Pathways
  2. GPCR/G Protein
  3. Ras


Ras is the name given to a family of related proteins which is ubiquitously expressed in all cell lineages and organs. All Ras protein family members belong to a class of protein called small GTPase, and are involved in transmitting signals within cells. Ras is the prototypical member of the Ras superfamily of proteins, which are all related in 3D structure and regulate diverse cell behaviours. When Ras is 'switched on' by incoming signals, it subsequently switches on other proteins, which ultimately turn on genes involved in cell growth, differentiation and survival. As a result, mutations in ras genes can lead to the production of permanently activated Ras proteins. This can cause unintended and overactive signalling inside the cell, even in the absence of incoming signals. Because these signals result in cell growth and division, overactive Ras signaling can ultimately lead to cancer. The 3 Ras genes in humans (HRAS,KRAS, and NRAS) are the most common oncogenes in human cancer; Ras inhibitors are being studied as a treatment for cancer, and other diseases with Ras overexpression.

Ras Isoform Specific Products:

  • K-Ras

  • H-Ras

Ras Related Products (62):

Cat. No. Product Name Effect Purity
  • HY-U00418
    ARS-1620 Inhibitor 98.66%
    ARS-1620 is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
  • HY-19706
    ARS-853 Inhibitor 98.39%
    ARS-853 is a selective, covalent KRASG12C inhibitor with an IC50 of 2.5 μM.
  • HY-114277
    AMG-510 Inhibitor 99.60%
    AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor, which locks KRAS G12C in an inactive GDP-bound state. AMG-510 selectively targets the KRAS p.G12C mutant and shows anti-tumor activity.
  • HY-15723A
    NSC 23766 trihydrochloride Inhibitor 99.10%
    NSC 23766 trihydrochloride is an inhibitor of Rac1 activation.
  • HY-101295
    Pan-RAS-IN-1 Inhibitor >98.0%
    Pan-RAS-IN-1 is a pan-Ras inhibitor that disrupts the interaction of Ras proteins and their effectors.
  • HY-114436
    MRTX-1257 Inhibitor 98.57%
    MRTX-1257 is a selective, irreversible, covalent and oral active KRAS G12C inhibitor, with an IC50 of 900 pM for KRAS dependent ERK phosphorylation in H358 cells.
  • HY-126247
    BI-2852 Inhibitor
    BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity. BI-2852 is mechanistically distinct from covalent KRASG12C inhibitor (binds to switch II pocket) because it binds to a different pocket present in both the active and inactive forms of KRAS. BI-2852 blocks GEF, GAP, and effector interactions with KRAS, leading to inhibition of downstream signaling and an antiproliferative effect in KRAS mutant cells.
  • HY-12755
    ML141 Inhibitor 99.21%
    ML141(CID-2950007) is a potent, selective and reversible non-competitive inhibitor of Cdc42 GTPase(IC50=200 nM) with low micromolar potency and selectivity against other members of the Rho family of GTPases (Rac1, Rab2, Rab7).
  • HY-12646
    Rhosin hydrochloride Inhibitor 99.97%
    Rhosin hydrochloride is a potent, specific RhoA subfamily Rho GTPases inhibitor, which specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin hydrochloride induces cell apoptosis.
  • HY-14754
    Salirasib Inhibitor 98.72%
    Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.
  • HY-12874
    CASIN Inhibitor 98.64%
    CASIN is a selective GTPase Cdc42 inhibitor with IC50 of 2 uM.
  • HY-16659
    EHT 1864 Inhibitor 99.60%
    EHT 1864 is a small molecule inhibitor of Rac1 signaling; modulate γ-Secretase-mediated APP processing.
  • HY-104064
    1A-116 Inhibitor 99.28%
    1A-116 is a specific Rac1 inhibitor.
  • HY-12810
    EHop-016 Inhibitor 99.36%
    EHop-016 is a novel potent and selective inhibitor of Rac GTPase; inhibits Rac1 activity in MDA-MB-435 cells with an IC50 of 1.1 uM.
  • HY-13991
    CCG-1423 Inhibitor 99.92%
    CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.
  • HY-100876
    GGTI298 Inhibitor
    GGTI298 is a CAAZ peptidomimetic geranylgeranyltransferase I (GGTase I) inhibitor, strongly inhibiting the processing of geranylgeranylated Rap1A with little effect on processing of farnesylated Ha-Ras, with IC50 values of 3 and > 20 μM in vivo, respectively.
  • HY-18707
    K-Ras(G12C) inhibitor 12 Inhibitor >98.0%
    K-Ras(G12C) inhibitor 12 is a K-Ras(G12C) inhibitor, the half-maximum effective concentration (EC50) for K-Ras(G12C) inhibitor 12 in H1792 cells is 0.32 μM.
  • HY-U00417
    ARS-1630 Inhibitor 98.01%
    ARS-1630, a less active enantiomer of ARS-1620, is a novel inhibitor of mutant K-ras G12C extracted from patent WO 2015054572 A1.
  • HY-12649
    Y16 Inhibitor
    Y16 is a specificity inhibitor of the heterotrimeric G-protein-regulated RhoGEFs with a Kd value of 76 nM. Y16 also has specific inhibitory activity of LARG.
  • HY-13963
    ZCL278 Inhibitor
    ZCL278 is a selective Cdc42 modulator that directly binds to Cdc42 and inhibits its functions with Kd of 11.4 μM for Cdc42-ZCL278 affinity in surface plasmon resonance (SPR) experiment.
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.